Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Ejhaem|October 17, 2024
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapyNicole Lamanna, Constantine S Tam, Jennifer A Woyach, et al.
The New England Journal of Medicine|June 2, 2018
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.
British Journal of Haematology|March 18, 2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphomaNathan H Fowler, Loretta Nastoupil, Sven De Vos, et al.
Blood|June 9, 2022
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphomaPaola Ghione, M Lia Palomba, Anik R Patel, et al.
Blood Advances|January 26, 2021
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissueErel Joffe, Yan Leyfman, Esther Drill, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
British Journal of Haematology|August 16, 2023
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvementChristine E Ryan, Rebecca L Zon, Robert Redd, et al.
Blood|December 8, 2018
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J Castillo, Gilad Itchaki, Jonas Paludo, et al.
Plos One|February 4, 2014
Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cellsM Lia Palomba, Kelly Piersanti, Carly G K Ziegler, et al.
Pageof 12